Anti-angiogenic effect of KH902 on retinal neovascularization (Q44897871)

7 December 2017

Anti-angiogenic effect of KH902 on retinal neovascularization (English)

1 reference

7 December 2017

1 reference

angiogenesis inhibitor

1 reference

Fei Wang

1

1 reference

7 December 2017

Yujing Bai

2

1 reference

7 December 2017

Wenzhen Yu

3

1 reference

7 December 2017

Na Han

4

1 reference

7 December 2017

Lvzhen Huang

5

1 reference

7 December 2017

Min Zhao

6

1 reference

7 December 2017

Aiyi Zhou

7

1 reference

7 December 2017

Mingwei Zhao

8

1 reference

7 December 2017

Xiaoxin Li

9

1 reference

7 December 2017

6 June 2013

1 reference

Graefe's Archive for Clinical and Experimental Ophthalmology

7 December 2017

1 reference

7 December 2017

251

1 reference

7 December 2017

2131-2139

1 reference

7 December 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1007/s00417-013-2392-6

7 December 2017

0 references

cites work

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York state patient database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

Advances in combination of antiangiogenic agents targeting VEGF-binding and conventional chemotherapy and radiation for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

Ephrin-a4 is involved in retinal neovascularization by regulating the VEGF signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

Intravitreal pegaptanib as adjunctive treatment for stage 3+ ROP shown to be effective in a prospective, randomized, controlled multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

p38 Mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

Effects of intravitreal injection of KH902, a vascular endothelial growth factor receptor decoy, on the retinas of streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

Soluble vascular endothelial growth factor decoy receptor FP3 exerts potent antiangiogenic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

Pharmacokinetics of a long-lasting anti-VEGF fusion protein in rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00417-013-2392-6

21 January 2018

12 December 2020

Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1

1 reference

12 December 2020

Pathogenesis of retinopathy of prematurity

1 reference

12 December 2020

Retinopathy of prematurity

1 reference

12 December 2020

Oxygen-induced retinopathy in the mouse

1 reference

12 December 2020

Erythropoietin deficiency decreases vascular stability in mice.

1 reference

12 December 2020

Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting.

1 reference

12 December 2020

A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration

1 reference

12 December 2020

Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases

1 reference

12 December 2020

Jun N-terminal kinase inhibitor blocks angiogenesis by blocking VEGF secretion and an MMP pathway

1 reference

12 December 2020

Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization

1 reference

12 December 2020

Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys

1 reference

12 December 2020

Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.

1 reference

12 December 2020

FP3: a novel VEGF blocker with antiangiogenic effects in vitro and antitumour effects in vivo

1 reference

12 December 2020

10.1007/S00417-013-2392-6

Identifiers

DOI

1 reference

7 December 2017

1 reference